Amsterdam, North Holland, Netherlands
About me: Co-founder and CEO of Publitas.com and co-organiser of the Amsterdam Ruby Group. Passionate about startups, delicious food, and exploring planet Earth. P.S. We're hiring! Have look :) -> https://www.publitas.com/jobs/
At Publitas.com we help retailers turn their catalogs, weekly ads, and magazines into beautiful online publications. Internationally operating retailers such as METRO Cash & Carry, Ahold, and the Carphone Warehouse use our software to increase their reach, brand engagement, and sales.
We’re a biotech startup that has developed an improved Monocyte Activation Test (MAT) for pyrogen testing. The MAT serves as the replacement for the Rabbit Pyrogen Test and amongst other can be used to test parenteral drugs for endotoxin and non-endotoxin contaminations. Our technology uses frozen pooled PBMC. This has made it possible to develop a MAT with both high sensitivity and robustness, ensuring reliability in the field. We’re currently in the soft-launch phase where we are working with interested parties who might be interested in our kit and/or expertise in MAT. Monocyte Activation Test (MAT) The Monocyte Activation Test (MAT) is a pyrogen test. MAT uses human blood cells to test for a fever reaction, mimicking the human immune reaction.The MAT serves as the replacement for the Rabbit Pyrogen Test and amongst other can be used to test parenteral drugs for endotoxin and non-endotoxin contaminations. Our technology uses frozen pooled PBMC. This has made it possible to develop a MAT with both high sensitivity and robustness, ensuring reliability in the field. The MAT kit includes all the required consumables to perform the Monocyte Activation Test, making it convenient to perform. In addition to the kit we provide consulting services and technical support in setting up the MAT in your organisation.
We are quantitative investment management startup. Our goal is to produce exceptional returns for our investors by strictly adhering to our risk management process trading strategy.
“GREAT THINGS MAY COME TO THOSE WHO WAIT, BUT ONLY THE THINGS LEFT BY THOSE WHO HUSTLE.” We do first stage investments and participations in SaaS, E-commerce and Pharma.